Are compounded bioidentical hormones safer? What the evidence says
There is no evidence that compounded bioidentical hormones are safer than approved hormone therapy. We explain what bioidentical means, the risks medical societies point to, why saliva testing is no use for adjusting the dose, and when a tailor-made formulation may actually be justified.

Short answer
Compounded bioidentical hormones have not been shown to be safer than approved hormone therapy: the 2020 NASEM report concluded that the evidence does not support their clinical usefulness. The same molecules, estradiol and micronised progesterone, are available as authorised medicines, including in Spain, and the choice always requires an individual medical assessment.
Key points
- According to the July 2020 report by the US National Academies of Sciences, Engineering, and Medicine (NASEM), there are few well-designed trials on compounded bioidentical hormones, and the support for them comes mainly from testimonials and anecdotes.
- In its 2022 position statement, The Menopause Society advises against prescribing them routinely when an approved alternative exists, because of the risk of overdosing, underdosing, impurities and lack of sterility.
- ACOG and ASRM Committee Opinion 532 (2012, reaffirmed in 2023) states that salivary hormone levels have no proven biological meaning.
- According to Pinkerton and Constantine, up to 2.5 million women aged 40 or over in the US, around 2%, may be using compounded hormones; there are no equivalent figures for Spain.
Bioidentical hormones: approved medicine versus compounded preparation
Comparison based on NASEM (2020) and The Menopause Society's position statement (2022).
| Aspect | Approved bioidentical medicine | Compounded bioidentical preparation |
|---|---|---|
| Molecule | Estradiol, micronised progesterone | Estradiol, progesterone or other combinations |
| Assessment of effectiveness and safety | Assessed by the regulator (in Spain, the AEMPS or EMA) before going on the market | Not assessed as a product; no scientific data on effectiveness and safety, according to The Menopause Society |
| Dose control | Dose verified in every batch | Risk of overdosing or underdosing |
| Quality and purity | Subject to manufacturing controls | Possible impurities and lack of sterility, according to The Menopause Society |
| Recommended use | First-choice option when hormone therapy is indicated | Only if an approved product cannot be used, according to NASEM |
No. No good-quality study has shown that compounded bioidentical hormones are safer or more effective than approved hormone therapy. In 2020, the US National Academies of Sciences, Engineering, and Medicine (NASEM) concluded that the evidence does not support their clinical usefulness. Many bioidentical hormones are also already available as authorised medicines, with controlled doses and prior regulatory assessment.
The important point is that bioidentical and compounded are not the same thing. Mixing the two up is behind much of the myth, so it helps to separate them before talking about risks.
What it means for a hormone to be bioidentical
A bioidentical hormone has exactly the same chemical structure as the one your body produces. In the menopause, the main ones are estradiol, the principal oestrogen of the reproductive years, and progesterone. They are made in a laboratory, usually from plant precursors, but that does not make them natural in the sense of harmless: a molecule identical to your own has real hormonal effects, both wanted and unwanted.
What often goes unsaid is that there are approved medicines containing exactly these molecules, such as estradiol and micronised progesterone. They form the basis of what is now considered modern hormone therapy, and we explain this in detail in how hormone therapy with estradiol and micronised progesterone works. Choosing bioidentical hormones, then, does not mean stepping outside authorised medicines.
What a compounded hormone preparation is
A compounded (extemporaneous) preparation is a medicine that a pharmacist makes up for a specific patient from a prescription, by mixing active ingredients and excipients. In English-speaking countries, the term compounded bioidentical hormone therapy is used for hormonal creams, capsules, gels or pellets prepared in this way, often in personalised combinations and doses.
The key difference from an authorised medicine is not the molecule but the process. An authorised medicine has had to prove to the regulator (in Spain, the AEMPS or the European Medicines Agency) that it is effective and safe, and that every batch contains what the pack says. A compounded preparation does not go through that assessment as a product: its quality depends on the individual preparation, and there are no trials backing each combination that gets prescribed.
What the evidence says: the US National Academies report
In July 2020, NASEM published a report commissioned by the US Food and Drug Administration to review the clinical usefulness of compounded bioidentical hormones. Its conclusions were clear: there are few well-designed trials, those that exist have serious methodological limitations, and much of the support for these preparations comes from testimonials and anecdotes rather than studies.
The report went further and described their widespread use as a public health problem, given the combination of a lack of good-quality evidence and limited oversight. It recommended restricting these preparations to patients who cannot use approved products.
The specific risks highlighted by menopause societies
The Menopause Society (formerly NAMS), in its 2022 position statement on hormone therapy, states that compounded bioidentical hormones should not be prescribed routinely when approved formulations are available. The reasons it lists are specific:
- Little regulation and monitoring of how they are prepared and which adverse effects are reported.
- Risk of overdosing or underdosing, because the actual amount of hormone may not match what was intended.
- Possible impurities in the preparation.
- Lack of sterility in some cases.
- No scientific data on their effectiveness or safety.
Underdosing has a practical consequence that often goes unnoticed. When a woman with a uterus uses oestrogen, progesterone protects the endometrium; if the actual dose is lower than expected, that protection is not guaranteed. The same position statement points out that hormone therapy remains the most effective treatment for hot flushes and night sweats, which underlines that the problem is not the hormones themselves but the lack of control over what is being taken.
Nor is there any data to support the claim that compounded bioidentical hormones carry a lower risk of breast cancer or thrombosis than approved hormone therapy. The idea is widely repeated, but it has not been proven. If you want to know how these risks are assessed with authorised medicines, we go through them in menopausal hormone therapy: who it is for and its real risks.
Saliva testing to adjust hormones: why it is not reliable
One of the selling points of tailor-made therapies is that the dose is adjusted according to hormone levels measured in saliva. The American College of Obstetricians and Gynecologists and the American Society for Reproductive Medicine (Committee Opinion 532, from 2012, reaffirmed in 2023) reject this: salivary hormone levels have no proven biological meaning, and the test is neither accurate nor precise.
This is because those levels vary with how the hormone is absorbed and cleared, the time of day, and a great deal of variability, both within the same woman and between different women. In clinical practice, hormone therapy is adjusted mainly according to how symptoms change and how well it is tolerated, not by chasing a number on a test.
Why they are so popular
The appeal is understandable: the promise of something natural, personalised and free of the risks associated with hormone therapy. In the US, a study by Pinkerton and Constantine published in Menopause estimated that up to 2.5 million women aged 40 or over might be using compounded bioidentical hormones, around 2% of women in the country, and that between 28% and 68% of women taking hormones for the menopause might be using this type of preparation. These are estimates extrapolated from surveys and apply only to the US; we have not found equivalent figures for Spain.
Something similar happens with other products marketed as natural remedies for the menopause. In what works and what doesn't among phytoestrogens, isoflavones and supplements we apply the same standard: what matters is the evidence, not the label.
When a compounded preparation can make sense
Saying that compounded hormones should not be the routine option is not the same as saying they are never justified. The NASEM report itself allows for exceptions: patients who are allergic to an excipient in commercial products, or who need a dose or route of administration that is not available on the market. In those cases, the preparation meets a specific need that the authorised medicine does not, and it is an individual medical decision.
The situation in Spain
In Spain, micronised progesterone medicines are on the market, in other words approved bioidentical products, as are estradiol preparations. Compounded preparations also exist and are made up in pharmacies on prescription, but we have not found any public data on how many women use compounded hormones, nor a specific position statement on them from the Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia). The conclusions in this article are therefore based on the international medical societies cited.
Key takeaways
Bioidentical does not mean compounded, and natural does not mean safer: the same hormones are available as approved medicines, with verified doses and prior assessment, and no medical society supports the idea that compounded is better. In Spain today, anyone looking for relief from menopausal symptoms can access menopause treatment with a medical assessment first, a prescription from a registered doctor when it is indicated, and ongoing follow-up, which is what AiON offers; you can find the full picture in how menopause treatment by telemedicine works in Spain. If you'd like to know whether it could be an option for you, you can:
Check in a few minutes whether the treatment is right for you
Sources
- National Academies (NASEM): Prescribers should restrict the use of non-FDA-approved compounded bioidentical hormones (2020)
- FDA sobre el estudio NASEM de hormonas bioidénticas compuestas
- The Menopause Society (NAMS): posicionamiento sobre terapia hormonal 2022
- Revisión en Healthcare (2021) que recoge ACOG/ASRM Committee Opinion 532
- ScienceDaily sobre Pinkerton JV, Constantine GD, Menopause
The guide explains. The doctor decides.
Online assessment, prescription where appropriate and ongoing follow-up.
Frequently asked questions
- Are bioidentical hormones natural and therefore risk-free?
No. Being identical to the body's own hormones does not make them harmless: they act just like your own hormones, with both wanted and unwanted effects. They are also made in a laboratory, including compounded ones.
- Can a saliva test be used to adjust my hormone dose?
Not reliably. ACOG and ASRM state that salivary hormone levels have no proven biological meaning and vary with the time of day, absorption and from one woman to another. The dose is usually adjusted according to symptoms and tolerability.
- Do compounded bioidentical hormones have a lower risk of breast cancer or thrombosis?
There is no data to show this. No good-quality studies compare these risks with those of approved hormone therapy, and medical societies specifically point to the lack of safety data.
- Are there approved bioidentical hormones in Spain?
Yes. Medicines containing micronised progesterone and estradiol, which are bioidentical molecules, are available in Spain. Using bioidentical hormones does not require a compounded preparation.
- When is a compounded hormone preparation justified?
According to NASEM, when the patient cannot use approved products, for example because of an allergy to an excipient or because she needs a dose or form that is not available on the market. It is an individual medical decision, not the routine option.
Keep reading
Migraine with aura at the menopause: can you take hormone therapy, and which options are safe?
Migraine with aura does not on its own rule out menopausal hormone therapy, but it does change how the treatment is approached. Oestrogen is given through the skin (transdermally), at the lowest dose that works, and the aura is monitored. We explain what the evidence says, why stroke is a concern and which non-hormonal alternatives are available in Spain.
ReadTreatment with and without hormonesCan I take hormone therapy if I have had a thrombosis, or have high blood pressure or excess weight? When it is possible and which route to use
If you have high blood pressure or excess weight, menopausal hormone therapy can usually still be considered, and guidelines prefer a patch or gel. A previous thrombosis changes things. We explain what the studies show, why the route matters so much and what the Spanish summaries of product characteristics say.
ReadTreatment with and without hormonesStarting hormone therapy at 60 or over: when it is reconsidered and what the alternatives are
From the age of 60, or more than 10 years after your last period, the balance of hormone therapy changes. We explain what age-based trials show, when it is reconsidered and what local and hormone-free options exist in Spain.
Read




